TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | -3 | -2 | 13 | 224 | -33 | 34 |
| P | %wins | 67 | 33 | 67 | 67 | 67 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/7/15 09:21 | 10/6/15 | CPXX | Celator Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Jackson Scott Thomas | NJ | DO | CEO | P | 25 | 1.74 | 1 | 14 | 41 | 50 | D | -68 | -31 | -29 | -15 | -14 | -22 | -11 | 8 | 5 | -1 | 2 | 4 | 679 | |
11/18/14 16:00 | 11/18/14 | CPXX | Celator Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Jackson Scott Thomas | NJ | DO | CEO | P | 22 | 2.20 | 0 | 10 | 333 | 13 | D | -39 | -14 | -21 | -14 | -5 | -1 | 6 | -4 | -11 | -14 | 37 | 6 | -20 | |
12/17/13 16:07 | 12/17/13 | CPXX | Celator Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Jackson Scott Thomas | NJ | DO | CEO | P | 10 | 3.50 | 0 | 3 | New | 3 | D | -37 | 7 | 0 | 0 | 3 | 3 | 3 | 7 | -2 | -13 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |